Journal article
Melioidosis of the Central Nervous System: Impact of the bimABm Allele on Patient Presentation and Outcome
H Gora, T Hasan, S Smith, I Wilson, M Mayo, C Woerle, JR Webb, BJ Currie, J Hanson, EM Meumann
Clinical Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2024
DOI: 10.1093/cid/ciac111
Abstract
Background. The autotransporter protein Burkholderia intracellular motility A (BimA) facilitates the entry of Burkholderia pseudomallei into the central nervous system (CNS) in mouse models of melioidosis. Its role in the pathogenesis of human cases of CNS melioidosis is incompletely defined. Methods. Consecutive culture-confirmed cases of melioidosis at 2 sites in tropical Australia after 1989 were reviewed. Demographic, clinical, and radiological data of the patients with CNS melioidosis were recorded. The bimA allele (bimABm or bimABp) of the B. pseudomallei isolated from each patient was determined. Results. Of the 1587 cases diagnosed at the 2 sites during the study period, 52 (3.3%) ha..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The work was supported by the Australian National Health and Medical Research Council (grant numbers 1046812, 1098337, and 1131932) (the HOT NORTH initiative).